EUVIMEDEUVIMED entdecken
Systematische Übersicht

Interventions to help patients withdraw from depression drugs: A systematic review

Peter C Gøtzsche, Maryanne Demasi

International Journal of Risk & Safety in Medicine · 2024

DOI: 10.3233/jrs-230011 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Risk & Safety in Medicine, 2024. Verfasst von Peter C Gøtzsche und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Scientific Freedom, Hørsholm, Denmark. Hauptthemen laut MEDLINE: Antidepressive Agents, Substance Withdrawal Syndrome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 84 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Depression drugs can be difficult to come off due to withdrawal symptoms. Gradual tapering with tapering support is needed to help patients withdraw safely. OBJECTIVE: To review the withdrawal success rates, using any intervention, and the effects on relapse/recurrence rates, symptom severity, quality of life, and withdrawal symptoms. METHODS: Systematic review based on PubMed and Embase searches (last search 4 October 2022) of randomised trials with one or more treatment arms aimed at helping patients withdraw from a depression drug, regardless of indication for treatment. We calculated the mean and median success rates and the risk difference of depressive relapse when discontinuing or continuing depression drugs. RESULTS: We included 13 studies (2085 participants). Three compared two withdrawal interventions and ten compared drug discontinuation vs. continuation. The success rates varied hugely between the trials (9% to 80%), with a weighted mean of 47% (95% confidence interval 38% to 57%) and a median of 50% (interquartile range 29% to 65%). A meta-regression showed that the length of taper was highly predictive for the risk of relapse ( P = 0.00001). All the studies we reviewed confounded withdrawal symptoms with relapse; did not use hyperbolic tapering; withdrew the depression drug too fast; and stopped it entirely when receptor occupancy was still high. CONCLUSION: The true proportion of patients on depression drugs who can stop safely without relapse is likely considerably higher than the 50% we found.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antidepressive AgentsSubstance Withdrawal SyndromeHumansRecurrenceQuality of LifeDepressionRandomized Controlled Trials as TopicDrug Tapering

Stichwörter der Autor:innen

Depression drugsrelapsetaperingwithdrawal symptoms

Substanzen

Antidepressive Agents

Autor:innen und Institutionen

  • Institute for Scientific Freedom, Hørsholm, Denmark.

Zitieren

APA

Gøtzsche, P. C., & Demasi, M. (2024). Interventions to help patients withdraw from depression drugs: A systematic review. International Journal of Risk & Safety in Medicine. https://doi.org/10.3233/jrs-230011

Vancouver

Gøtzsche PC, Demasi M. Interventions to help patients withdraw from depression drugs: A systematic review. International Journal of Risk & Safety in Medicine. 2024. doi:10.3233/jrs-230011

BibTeX
@article{Gtzsche2024,
  author = {Gøtzsche, Peter C and Demasi, Maryanne},
  title = {Interventions to help patients withdraw from depression drugs: A systematic review},
  journal = {International Journal of Risk & Safety in Medicine},
  year = {2024},
  doi = {10.3233/jrs-230011}
}
Kostenlos starten →